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In the past decade, scientific discovery in medicine has pro-
gressed at an increasingly rapid rate, and genomic, post-
genomic and bioinformatic approaches have played key roles
in this progression. Our growing understanding of the
human genome and proteome promises to revolutionize the
practice of medicine in the 21st century. The last year has
seen the publication of an acute myeloid leukemia genome
[1], the initiation of the 1000 Genomes Project [2] and the
International Human Microbiome Consortium, and the
progression of a number of other important collaborations,
such as the Copy Number Variation Project [3] and the
Cancer Genome Atlas [4]. Furthermore, a plethora of
genome-wide association studies have been undertaken,
associating specific loci to a variety of diseases. These
discoveries, as well as continuing advances in genome
sequencing technologies, bring us several steps closer to
individualized medicine, a concept that has captured the
imaginations of practitioners of medicine, politicians, and
the public alike.
In these exciting and fast-moving times, there is a clear need
for the scientific community to keep abreast of the latest
groundbreaking genomic and post-genomic research across
medical disciplines. To this end, we are proud to launch
Genome Medicine.  Genome Medicine publishes important
results in genomic and post-genomic medicine, discusses the
importance of these results for clinical practice, highlights
the major issues surrounding genomic medicine, and
comments on the progress of scientific discovery.
The journal, led by six renowned Section Editors and sup-
ported by an impressive international Editorial Board,
publishes open access research articles of outstanding
quality in all areas of medicine studied from a genomic or
post-genomic perspective. Genome Medicine is committed
to the open access publication of research – the concept
has been embraced by the research community and by
major funding bodies, including the NIH and the Wellcome
Trust, because it maximizes research visibility and facili-
tates the most rapid dissemination of scientific knowledge.
In short, open access publication of research findings is
fundamental to the progress of scientific discovery as well
as clinical practice.
The scope of the journal is broad and includes articles aimed
at understanding the genetics, genomics and epigenetics of
disease, genomic epidemiology, and public health genomics,
as well as articles that utilize computational and systems
approaches to advance our understanding of the patho-
genesis, diagnosis and management of disease. The journal
has a particular emphasis on the application of genomic and
post-genomic technologies to clinical practice, especially to
diagnostics and therapeutics.
Medicine’s move towards the post-genomic era is accom-
panied by a wide range of ethical, social, and legal implica-
tions that deserve careful attention. Genome Medicine
features an entire section devoted to the challenges relating
to genomic medicine and personalized medicine. Given our
limited knowledge of gene-gene and epigenetic interactions,
the translation of the results of genome-wide association
studies into an individual risk assessment is controversial at
best, and yet there are already a number of commercial
ventures purporting to provide this service to those who pay
for it. There are further issues surrounding the routine use of
genomic data in medical research and practice including
concerns about privacy, discrimination, consent, equity of
access, and the divide between developed and developing
countries.  Genome Medicine provides a forum for the
analysis and discussion of these and other issues associated
with post-genomic medicine.
In addition to peer-reviewed research articles, the journal
also features additional content, including regular commen-
tary from key experts in various fields. For insightful
analysis and opinion about post-genomic medicine, see the
monthly ‘Musings on genome medicine’ column by Stuart
Orkin and David G Nathan. Their inaugural column [5]
highlights some of the promises and problems surrounding
genome-wide association studies. For more comprehensive
coverage of emerging and established areas of research, our
reviews and minireviews will be of interest: in the currentissue, Charles Auffray, Zhu Chen and Leroy Hood discuss
the importance of systems medicine to the future of
healthcare [6], while Que Van and Timothy Veenstra discuss
the challenges and opportunities in regards to metabolic
profiling in cancer research [7]. The journal will also feature
correspondence pieces, such as the article by Timothy
Caulfield et al. discussing the challenges inherent in the use
of race and ancestry in biomedical research [8].
Looking to the future, medical researchers in all disciplines
will need to embrace genomic and post-genomic approaches
and technologies, and all those who diagnose and treat
patients will need to understand the science of medical
genomics in order to practice medicine effectively. Genome
Medicine will assist scientists and clinicians in better
understanding the evolving medical landscape and in
translating the most recent advances to their patients.
Of course, as the field of medical genomics changes, Genome
Medicine  will also evolve to provide you, the reader, the
information you need. We can only do this with your support
and input, so tell us your opinions of the journal, as well as
your suggestions for the future. We are committed to making
Genome Medicine a success, and we look forward to working
with you to shape medicine in the post-genomic era.
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